 OraSure Technologies Inc NASDAQ: OSUR has secured a 109 million contract from the U.S. Department of Defense to build additional manufacturing capacity in the U.S. for InteliSwab COVID-19 rapid tests. Related: OraSure Secures 13.6M BARDA Funding For InteliSwab COVID-19 Test 510k Clearance and CLIA Waiver. 